World's Best Scientists 2026 revealed!
Peter Karayiannis

Peter Karayiannis

D-Index & Metrics

Immunology

D-Index
55
Citations
13601
World Ranking
3784
National Ranking
1

Overview

Peter Karayiannis is affiliated with the University of Nicosia in Cyprus and has concentrated their research primarily in the field of Medicine, with a particular focus on subfields such as Epidemiology, Infectious Diseases, Hepatology, Neurology, and Public Health, Environmental and Occupational Health.

The main topics addressed in their work include:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and Mental Health
  • Phosphodiesterase function and regulation

Among the recent papers published by Peter Karayiannis are:

  • "New Approaches to the Treatment of Chronic Hepatitis B," 2020, Journal of Clinical Medicine
  • "Extensive Testing and Public Health Interventions for the Control of COVID-19 in the Republic of Cyprus between March and May 2020," 2020, Journal of Clinical Medicine
  • "Developing a holistic contingency plan: Challenges and dilemmas for cancer patients during the COVID-19," 2020, Cancer Medicine
  • "Circulating IgG Levels in SARS-CoV-2 Convalescent Individuals in Cyprus," 2021, Journal of Clinical Medicine
  • "Development of hepatic pathology in GBV-B-infected red-bellied tamarins (Saguinus labiatus)," 2020, Journal of Medical Virology

Frequent collaborators include:

  • Annalisa Quattrocchi
  • Mark Thursz
  • Fouzia Sadiq
  • Julia A. Tree
  • David W. C. Beasley

Peter Karayiannis's work is commonly published in venues such as:

  • Journal of Clinical Medicine
  • Journal of General Virology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Medicine
  • Journal of Medical Virology

Best Publications

  • Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

    Jeff Linnen;John Wages;Zhen-Yong Zhang-Keck;Kirk E. Fry

  • MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

    W.F Carman;S Hadziyannis;M.J Mcgarvey;M.R Jacyna

  • Vaccine-induced escape mutant of hepatitis B virus

    W.F. Carman;P. Karayiannis;J. Waters;H.C. Thomas

  • Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum

    Chia‐Ming ‐M Chu;Peter Karayiannis;Martin J.F. Fowler;Jon Monjardino

  • Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors

    M. Gary Brook;Peter Karayiannis;Howard C. Thomas

  • Identification of Unique Hepatitis C Virus Quasispecies in the Central Nervous System and Comparative Analysis of Internal Translational Efficiency of Brain, Liver, and Serum Variants

    Daniel M. Forton;Peter Karayiannis;Nadiya Mahmud;Simon D. Taylor-Robinson

  • Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen–negative Chinese carriers

    Jinlin Hou;Zhanghui Wang;Jinjun Cheng;Yulong Lin

  • Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV.

    Emma C Thomson;Eleni Nastouli;Janice Main;Peter Karayiannis

  • Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men

    Emma C Thomson;Vicki M Fleming;Janice Main;Paul Klenerman

  • Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV‐III antibodies to recombinant α‐interferon

    J. A. McDonald;J. A. McDonald;L. Caruso;L. Caruso;P. Karayiannis;P. Karayiannis;L. J. Scully;L. J. Scully

  • Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow.

    J.Z. Wimperis;H.G. Prentice;P. Karayiannis;M.K. Brenner

  • High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin.

    P. B. A. Kernoff;C. A. Lee;P. Karayiannis;H. C. Thomas

  • Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen.

    Siamak Seddigh-Tonekaboni;Jennifer A. Waters;Sarah Jeffers;Ralph Gehrke

  • Effect of basal core promoter and pre-core mutations on hepatitis B virus replication.

    Saffie Jammeh;Fiona Tavner;Roger Watson;Howard C. Thomas

  • A double blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection

    J. Main;J. L. Brown;C. Howells;R. Galassini

  • Hepatitis B virus: old, new and future approaches to antiviral treatment

    Peter Karayiannis

  • A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers

    Jinlin Hou;Peter Karayiannis;Jenny Waters;Kangxian Luo

  • Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.

    A. S.F. Lok;S. J. Hadziyannis;I. V.D. Weller;M. G. Karvountzis

  • Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis.

    Uga Dumpis;Uga Dumpis;Edward Charles Holmes;Maimuna Mendy;Adrian Hill

  • Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

    M. G. Brook;J. A. Mcdonald;P. Karayiannis;L. Caruso

Frequent Co-Authors

Howard C. Thomas
Howard C. Thomas Imperial College London
Robert D. Goldin
Robert D. Goldin Imperial College London
Stephanos J. Hadziyannis
Stephanos J. Hadziyannis National and Kapodistrian University of Athens
Mark Thursz
Mark Thursz Imperial College London
William F. Carman
William F. Carman University of Glasgow
Tatsuo Miyamura
Tatsuo Miyamura National Institutes of Health
Seyed Moayed Alavian
Seyed Moayed Alavian Baqiyatallah University of Medical Sciences
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Sheila Sherlock
Sheila Sherlock The Royal Free Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring allied healthcare fields can broaden career opportunities. Many who study Immunology go on to work in clinical or research settings that overlap with nursing specialties. If you are considering a more clinical role, Licensed Practical Nurse (LPN) programs are a great entry point. For those seeking manageable requirements, several which LPN programs are easiest to get into can provide a smooth transition into nursing careers.

Advancing beyond LPN, nurse practitioners have significant roles in patient care. Prospective students might explore nurse practitioner programs with easy admission to find flexible entry options. These programs often emphasize specialties where immunological knowledge is valuable, such as mental health.

Psychiatric Mental Health Nurse Practitioner (PMHNP) careers are particularly relevant for Immunology graduates interested in neuroimmune and psychoneuroimmunology fields. Some of the best psychiatric mental health nurse practitioner programs online offer excellent clinical placement support to prepare students for real-world practice.

Cost is a major consideration for many students. Those wanting to balance quality with affordability should review the cheapest online PMHNP programs, which enable effective specialization without excessive financial burden.

Best Scientists Citing Peter Karayiannis

Trending Scientists

Recently Published Articles